scPharmaceuticals Inc (SCPH)
4.67
+0.11
(+2.41%)
USD |
NASDAQ |
May 02, 12:56
scPharmaceuticals Cash from Financing (Quarterly): 0.467M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.467M |
| September 30, 2023 | 0.068M |
| June 30, 2023 | 0.611M |
| March 31, 2023 | 13.70M |
| December 31, 2022 | 84.60M |
| September 30, 2022 | -2.477M |
| June 30, 2022 | -2.416M |
| March 31, 2022 | -2.479M |
| December 31, 2021 | -2.458M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.072M |
| December 31, 2020 | 0.02M |
| September 30, 2020 | -0.082M |
| Date | Value |
|---|---|
| June 30, 2020 | 49.95M |
| March 31, 2020 | 10.46M |
| December 31, 2019 | 3.897M |
| September 30, 2019 | 9.673M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.018M |
| December 31, 2018 | -0.061M |
| September 30, 2018 | -0.004M |
| June 30, 2018 | 0.001M |
| March 31, 2018 | 0.056M |
| December 31, 2017 | 92.41M |
| September 30, 2017 | -0.002M |
| June 30, 2017 | 9.676M |
| March 31, 2017 | -0.008M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.479M
Minimum
Mar 2022
84.60M
Maximum
Dec 2022
8.604M
Average
0.02M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Anika Therapeutics Inc | 0.342M |
| Spero Therapeutics Inc | 0.001M |
| electroCore Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.16M |
| Cash from Investing (Quarterly) | 26.46M |
| Free Cash Flow | -59.28M |
| Free Cash Flow Per Share (Quarterly) | -0.3917 |
| Free Cash Flow to Equity (Quarterly) | -15.74M |
| Free Cash Flow Yield | -32.96% |